Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Change in Account Payables (2020 - 2025)

iSpecimen has reported Change in Account Payables over the past 6 years, most recently at $666578.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $666578.0 for Q4 2025, up 368.67% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 355.69% YoY), and the annual figure for FY2025 was $1.2 million, up 355.69%.
  • Change in Account Payables for Q4 2025 was $666578.0 at iSpecimen, up from $456016.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for ISPC hit a ceiling of $1.6 million in Q4 2023 and a floor of -$2.9 million in Q3 2021.
  • Median Change in Account Payables over the past 5 years was $377573.0 (2021), compared with a mean of $182258.6.
  • Biggest five-year swings in Change in Account Payables: crashed 978.44% in 2021 and later soared 403.93% in 2025.
  • iSpecimen's Change in Account Payables stood at $481254.0 in 2021, then soared by 209.88% to $1.5 million in 2022, then increased by 10.32% to $1.6 million in 2023, then tumbled by 91.36% to $142229.0 in 2024, then surged by 368.67% to $666578.0 in 2025.
  • The last three reported values for Change in Account Payables were $666578.0 (Q4 2025), $456016.0 (Q3 2025), and $528876.0 (Q2 2025) per Business Quant data.